IPhone OS 2 market." iPhone OS 2 cost $9.95 for iPod Touch users; it was free for iPhone users. IPhone OS 2 iPhone OS 2 is the second major release of the iOS mobile operating system developed by Apple Inc., being the successor to iPhone OS 1. It was the first release of iOS to support third-party applications via the App Store. iPhone OS 2.2.1 was the final version of iPhone OS 2. It was succeeded by iPhone OS 3 on June 17, 2009. iPhone OS 2.0 became available on July 11, 2008 with the release of the iPhone 3G. Devices running 1.x
JUNQ and IPOD the late onset of neurodegenerative diseases. In such diseases (e.g. Huntington's disease), a mutated protein misfolds and becomes toxic to the cellular environment by various ways such as denaturating cytosolic proteins. Incompetent of degrading those toxic species, the cell must isolate them to avoid their hazardous interaction with the cellular proteome. The IPOD was shown to be the sub-cellular site to which toxic amyloidogenic proteins are sequestered to, hereby serving as a protective quality control compartment. In addition, it was suggested by the Lindquist group, that the IPOD is the site where yeast prions undergo a maturation process. Thus, the